financetom
Business
financetom
/
Business
/
Hugo Boss cuts full-year forecast on sagging China, UK demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hugo Boss cuts full-year forecast on sagging China, UK demand
Jul 16, 2024 1:27 AM

*

Expects FY sales at 4.20-4.35 bln euros, EBIT at 350-430

mln

euros

*

Q2 EBIT of 70 mln euros misses expectations

*

Shares fall 10%, hitting lowest level since April 2021

(Adds analyst comment in paragraph 4 and 7, shares in paragraph

6, context in paragraphs 8-9)

By Gursimran Mehar and Linda Pasquini

July 15 (Reuters) - German fashion house Hugo Boss

cuts its sales and earnings forecasts for the year,

citing weakening global consumer demand, especially in China and

the UK, sending its shares down as much as 10%.

It now expects full-year sales to fall between 4.20

billion euros ($4.58 billion) and 4.35 billion euros, compared

with a previous forecast of 4.30 billion to 4.45 billion euros.

It also anticipates its operating profit (EBIT) to be around

350 million euros to 430 million euros, down from a previous 430

million euros to 475 million euros. It reported operating profit

of 410 million euros in 2023.

Its second-quarter operating profit (EBIT) amounted to

70 million euros on a preliminary basis, representing a "massive

33% miss" compared with market expectations, Deutsche Bank

analyst Michael Kuhn wrote in a note to clients.

The premium clothing brand has been on an expansion drive,

increasing marketing spend and opening 102 new points of sale in

2023, but its shares have fallen this year as it warned of

slower sales growth.

Hugo Boss shares were down 9% at 36.7 euros by 0710 GMT,

hitting their lowest level since April 2021.

"The critical question now will be whether guidance has

been cut enough to de-risk 2024 and provide a clearing event

that the stock's narrative can rebuild from," analysts at

Jefferies wrote.

Hugo Boss' initial guidance for the year had already

disappointed

analysts expectations in March.

Along with its first-quarter results in May, the company

had

flagged

weaker demand in China and concerns about the U.S. consumer

sentiment ahead of presidential elections.

The world's biggest watchmaker Swatch and luxury group

Richemont flagged sluggish demand in China this week, while

Burberry ( BBRYF ) also issued a profit warning and scrapped its dividend

payment for the year.

($1 = 0.9179 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Singapore's Sea beats revenue estimates for fourth quarter
Singapore's Sea beats revenue estimates for fourth quarter
Mar 4, 2025
March 4 (Reuters) - Sea Ltd ( SE ) topped Wall Street estimates for fourth-quarter revenue on Tuesday, helped by strong growth in its financial services segment and e-commerce platform Shopee. The Southeast Asian technology conglomerate's revenue rose 36.9% to $4.95 billion in the fourth quarter, compared with analysts' estimate of $4.62 billion, according to data compiled by LSEG. ...
Honeywell nears $2.2 billion deal for pump-and-compressor maker Sundyne, WSJ reports
Honeywell nears $2.2 billion deal for pump-and-compressor maker Sundyne, WSJ reports
Mar 4, 2025
(Reuters) -Honeywell International ( HON ) is closing in on a nearly $2.2 billion deal to buy pump-maker Sundyne from private-equity firm Warburg Pincus, the Wall Street Journal reported on Tuesday. Honeywell ( HON ) and Sundyne did not immediately respond to Reuters' requests for comments. The industrial giant Honeywell ( HON ) last month announced its plans to split...
BeiGene Says FDA Approves Tevimbra for Esophageal Cancer First-Line Treatment
BeiGene Says FDA Approves Tevimbra for Esophageal Cancer First-Line Treatment
Mar 4, 2025
06:36 AM EST, 03/04/2025 (MT Newswires) -- BeiGene ( ONC ) said Tuesday the US Food and Drug Administration approved Tevimbra, in combination with platinum-containing chemotherapy, for the first-line treatment of certain adults with unresectable or metastatic esophageal squamous cell carcinoma. The company said the approval is based on a phase 3 study where Tevimbra combination therapy showed a statistically...
Ford to Recall up to 35,328 Vehicles Over Faulty Exterior Mirror LED Lights
Ford to Recall up to 35,328 Vehicles Over Faulty Exterior Mirror LED Lights
Mar 4, 2025
06:33 AM EST, 03/04/2025 (MT Newswires) -- Ford Motor ( F ) is recalling certain 2015-2017 Lincoln Navigator model vehicles due to faulty LED lights in the exterior mirror that could pose a fire risk, the U.S. National Highway Traffic Safety Administration said in a notification on Monday. The recall may affect a total of 35,328 vehicles. The NHTSA said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved